2LBA - Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2

Autor: Sonke, G.S., Hart, L.L., Campone, M., Erdkamp, F., Janni, W., Verma, S., Villanueva, C., Jakobsen, E., Alba, E., Wist, E., Favret, A.M., Bachelot, T., Hegg, R., Wheatley-Price, P., Souami, F., Sutradhar, S., Miller, M., Germa, C., Burris, H.A.
Zdroj: In European Journal of Cancer February 2017 72 Supplement 1:S1-S2
Databáze: ScienceDirect
Externí odkaz: